Several medications work similarly to Vyvanse (lisdexamfetamine), though the closest comparison is generic lisdexamfetamine itself, which is now available from over a dozen manufacturers at a fraction of the brand-name cost. Beyond the generic, other amphetamine-based and methylphenidate-based stimulants can provide comparable symptom control for ADHD, and a few non-stimulant options exist for people who can’t tolerate stimulants at all.
How Vyvanse Works in the Body
Understanding what makes Vyvanse unique helps clarify which alternatives are truly comparable. Vyvanse is a prodrug, meaning it’s inactive when you swallow it. The active ingredient, lisdexamfetamine, is dextroamphetamine bonded to an amino acid called lysine. Your red blood cells gradually strip away the lysine, releasing active dextroamphetamine into your bloodstream over roughly 10 to 14 hours in adults. This slow, rate-limited conversion is why the medication feels smooth and long-lasting rather than producing a sharp peak and crash.
That prodrug design also makes Vyvanse harder to misuse. Crushing or snorting it doesn’t speed up the conversion process the way it would with a traditional extended-release pill, because the activation depends on enzymes in your blood, not on how the pill dissolves.
Generic Lisdexamfetamine: The Closest Match
The most directly comparable option is generic lisdexamfetamine dimesylate. The FDA has approved generics from more than 15 manufacturers, available as capsules in strengths from 10 mg to 70 mg and as chewable tablets from 10 mg to 60 mg. These contain the same active compound as brand-name Vyvanse and work identically in the body.
The price difference is significant. The average retail price for brand-name Vyvanse hovers around $352, while generic versions can be found for roughly $60 to $100 with discount coupons. Most Medicare and commercial insurance plans cover generic lisdexamfetamine, often at a lower copay tier than the brand.
Adderall XR: The Most Common Swap
Adderall XR (extended-release mixed amphetamine salts) is the medication most frequently compared to Vyvanse. Both are amphetamine-based, both last through a full school or work day, and both treat the same symptoms. The key differences come down to composition and release mechanism.
Adderall XR contains a 3:1 mix of dextroamphetamine and levoamphetamine, delivered through a bead system that releases half the dose immediately and half about four hours later. Vyvanse delivers only dextroamphetamine, released gradually through the prodrug conversion. Some people find Vyvanse provides a smoother arc of focus, while others do well with the two-pulse approach of Adderall XR.
For dose conversion, the general ratio is about 2.6 to 1. A person taking 20 mg of Adderall would typically move to roughly 50 mg of Vyvanse, and 30 mg of Adderall translates to about 70 mg of Vyvanse. This isn’t a rigid formula, and your prescriber will adjust based on how you respond.
Dexedrine: Same Active Drug, Shorter Duration
Dexedrine (dextroamphetamine) is the immediate-release form of the exact same active molecule that Vyvanse releases in your body. It kicks in within 20 to 60 minutes but only lasts 4 to 6 hours, so most people need two or three doses per day. A sustained-release version (Dexedrine Spansule) extends that somewhat but still doesn’t match Vyvanse’s 10 to 14 hour duration. Dexedrine can be a useful option if you want shorter coverage, for instance on days when you only need focus for part of the day, or if you’re sensitive to the long tail of Vyvanse affecting your sleep.
Concerta and Other Methylphenidate Options
Concerta (extended-release methylphenidate) is the main non-amphetamine stimulant that matches Vyvanse in duration, providing roughly 10 to 12 hours of coverage. It works through a different mechanism: instead of increasing the release of dopamine and norepinephrine the way amphetamines do, methylphenidate primarily blocks the reuptake of these chemicals, keeping more of what your brain naturally produces available for longer.
In user-reported data, methylphenidate tends to produce slightly higher rates of appetite loss (14.3% vs. 12.7%) and insomnia (9.3% vs. 7.3%) compared to lisdexamfetamine, though individual experiences vary widely. Methylphenidate is less likely to cause dry mouth, which is a notable side effect for about 6% of lisdexamfetamine users.
Other methylphenidate formulations include Ritalin LA (8 hours), Focalin XR (up to 12 hours), and the Daytrana patch. The patch is a transdermal option that bypasses the digestive system entirely, which can matter for people with absorption issues or difficulty swallowing pills. It delivers methylphenidate through the skin over 9 hours of wear time, with effects continuing for a few hours after removal.
Non-Stimulant Alternatives
For people who can’t take stimulants due to side effects, heart conditions, or substance use concerns, several non-stimulant medications treat ADHD. These generally produce milder symptom improvement than stimulants but avoid the appetite suppression, insomnia, and cardiovascular effects that come with amphetamines and methylphenidate.
Strattera (atomoxetine) was the first non-stimulant approved for ADHD. It works by blocking norepinephrine reuptake and takes 4 to 6 weeks to reach full effect, unlike stimulants that work on the first day. Qelbree (viloxazine) is a newer non-stimulant option approved for both children and adults that also targets norepinephrine. Intuniv (guanfacine) and Kapvay (clonidine) are extended-release blood pressure medications repurposed for ADHD, most commonly prescribed for children or as add-ons to stimulant therapy.
None of these non-stimulants are considered equivalent to Vyvanse in terms of symptom control magnitude. They occupy a different treatment tier and are typically tried when stimulants aren’t an option.
For Binge Eating Disorder Specifically
Vyvanse holds a unique position as the only FDA-approved medication for moderate to severe binge eating disorder in adults. No other medication, stimulant or otherwise, has this specific approval. If you’re taking Vyvanse for binge eating and looking for alternatives, the generic lisdexamfetamine is your only equivalent option with the same indication. Prescribers sometimes use other medications off-label for binge eating, but those haven’t gone through the same regulatory approval process for that condition.
What Matters When Comparing
The right Vyvanse alternative depends on why you’re looking for one. If cost is the issue, generic lisdexamfetamine solves the problem directly. If you’re experiencing side effects like insomnia or appetite loss, switching drug classes from amphetamine to methylphenidate (or vice versa) often helps, since people who don’t tolerate one class frequently do fine with the other. If you need shorter coverage, an immediate-release option like Dexedrine or Ritalin gives you more control over timing. And if stimulants as a category aren’t working, non-stimulants like Strattera or Qelbree represent a fundamentally different approach worth exploring with your prescriber.